financetom
Business
financetom
/
Business
/
HF Sinclair Q3 Adjusted EPS, Revenue Decrease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
HF Sinclair Q3 Adjusted EPS, Revenue Decrease
Nov 3, 2024 3:39 PM

09:25 AM EDT, 10/31/2024 (MT Newswires) -- HF Sinclair ( DINO ) reported Q3 adjusted earnings Thursday of $0.51 per diluted share, down from $4.06 a year earlier.

Analysts polled by Capital IQ expected $0.33.

Revenue for the quarter ended Sept. 30 was $7.21 billion, down from $8.91 billion a year earlier.

Analysts surveyed by Capital IQ expected $7.11 billion.

The company's board approved a quarterly dividend of $0.50 per share, payable on Dec. 4 to shareholders on Nov. 21.

Price: 40.55, Change: -0.27, Percent Change: -0.66

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
FCC deletes reference to agency independence during US Senate hearing
FCC deletes reference to agency independence during US Senate hearing
Mar 10, 2026
(Adds comments by Trump, details, paragraphs 7-8 and 13, changes story identification tag used by some clients) * FCC website changed after questioning on agency's independence * Senator Lujan challenges FCC's independence claim * Trump's executive order restricts FCC's regulatory process By David Shepardson WASHINGTON, Dec 17 (Reuters) - The Federal Communications Commission on Wednesday deleted a longstanding reference to...
Arcutis Biotherapeutics Insider Sold Shares Worth $332,851, According to a Recent SEC Filing
Arcutis Biotherapeutics Insider Sold Shares Worth $332,851, According to a Recent SEC Filing
Mar 10, 2026
05:57 PM EST, 12/17/2025 (MT Newswires) -- Patrick Burnett, Executive Vice President and Chief Medical Officer, on December 15, 2025, sold 11,500 shares in Arcutis Biotherapeutics ( ARQT ) for $332,851. Following the Form 4 filing with the SEC, Burnett has control over a total of 98,307 common shares of the company, with 98,307 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1787306/000174198725000010/xslF345X05/wk-form4_1766012033.xml...
Kalaris Posts Positive Results from Macular Degeneration Drug Trial
Kalaris Posts Positive Results from Macular Degeneration Drug Trial
Mar 10, 2026
05:50 PM EST, 12/17/2025 (MT Newswires) -- Kalaris Therapeutics ( KLRS ) reported late Wednesday positive initial data from its Phase 1a trial of its investigational drug for treating naive neovascular AMD patients. The single ascending dose (SAD) trial showed the drug candidate, TH103, had clinically meaningful improvements in vision and retinal anatomy. The trial also indicated early signs of...
BP Appoints Meg O'Neill as Chief Executive Officer
BP Appoints Meg O'Neill as Chief Executive Officer
Mar 10, 2026
05:54 PM EST, 12/17/2025 (MT Newswires) -- BP (BP) said late Wednesday it appointed Meg O'Neill as chief executive officer, starting April 1, 2026. O'Neill will succeed Murray Auchincloss, who will step down as CEO and board director on Dec. 18. Auchincloss will continue in an advisory role until December 2026 to support the transition. Carol Howle, executive vice president...
Copyright 2023-2026 - www.financetom.com All Rights Reserved